These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24544992)

  • 21. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. VI. Metasarcolysin.
    AUSTIN C; BERGSAGEL DE; SPRAGUE CC
    Cancer Chemother Rep; 1962 Aug; 21():107-12. PubMed ID: 13863325
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. III. AB-100 (NSC-37095).
    BROWN CL; BERGSAGEL DE; LEVIN WC
    Cancer Chemother Rep; 1962 Aug; 21():81-5. PubMed ID: 13873596
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. I. Plan of study.
    BERGSAGEL DE; SPRAGUE CC; ROSS SW
    Cancer Chemother Rep; 1962 Aug; 21():69-74. PubMed ID: 13867795
    [No Abstract]   [Full Text] [Related]  

  • 24. [A case of successful treatment with sarcolysin of a patient with myeloma].
    BAISOGOLOV GD; DOSHCHENKO VN; CHIZH AS
    Probl Gematol Pereliv Krovi; 1961 Aug; 6():51-4. PubMed ID: 13864079
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of multiple myeloma with I-aminocyclopentanecarboxylic acid (NSC-1026).
    KRANT MJ; ISZARD DM; ABADI A; CAREY RW
    Cancer Chemother Rep; 1962 Sep; 22():59-64. PubMed ID: 14459328
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of plasmocytoma with prednisolone].
    THEDERING F; VUELLERS R
    Blut; 1959 Jul; 5():161-5. PubMed ID: 13837676
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of patients with plasmocytoma].
    SANDKUHLER S
    Medizinische; 1956 Nov; 24(45):1601-3. PubMed ID: 13377999
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. V. 1-Aminocyclopentanecarboxylic acid (NSC-1026).
    BERGSAGEL DE; ROSS SW; BAKER DT
    Cancer Chemother Rep; 1962 Aug; 21():101-6. PubMed ID: 13867792
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. II. Mitomycin C (NSC-26980).
    BERGSAGEL DE; ROSS SW; DAVIS P
    Cancer Chemother Rep; 1962 Aug; 21():75-80. PubMed ID: 13867793
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. IV. L-Phenylalanine mustard (NSC-8806).
    BERGSAGEL DE; SPRAGUE CC; AUSTIN C; GRIFFITH KM
    Cancer Chemother Rep; 1962 Aug; 21():87-99. PubMed ID: 13867794
    [No Abstract]   [Full Text] [Related]  

  • 31. [Massive doses of prednisone in the treatment of plasmocytoma].
    BAGUENA CANDELA R; FORTEZA BOVER G
    Med Esp; 1962 Feb; 47():126-9. PubMed ID: 13863951
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparative study of optimal medical care with and without azaserine in multiple myeloma.
    HOLLAND JF
    Clin Pharmacol Ther; 1961; 2():22-8. PubMed ID: 13715278
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of multiple myeloma with radioactive iodine and radioactive iodinated serum albumin.
    KRISS JP; BIERMAN HR; THOMAS SF; NEWELL RR
    Radiology; 1955 Aug; 65(2):241-9. PubMed ID: 13245970
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of multiple myelomatosis with particular reference to radioactive iodine. Report of five cases.
    KAY HE; LEDLIE EM; SBRESNI RC
    Br J Radiol; 1959 Dec; 32():791-7. PubMed ID: 14404987
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase II trials of mitomycin C, AB-100, NSC-1026, L-sarcolysin, and meta-sarcolysin, in the treatment of multiple myeloma.
    BERGSAGEL DE
    Cancer Chemother Rep; 1962 Feb; 16():261-66. PubMed ID: 13867796
    [No Abstract]   [Full Text] [Related]  

  • 36. Fatal duodenal perforation during prednisone therapy.
    KELLOCK IA; SCLARE G
    Br Med J; 1957 Apr; 1(5024):930-1. PubMed ID: 13413256
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of malignant systemic diseases].
    VIDEBAEK A
    Nord Med; 1956 Mar; 55(10):320-3. PubMed ID: 13309805
    [No Abstract]   [Full Text] [Related]  

  • 38. Urethane-induced hepatic failure in man.
    WEISS DL; DE LOS SANTOS R
    Am J Med; 1960 Mar; 28():476-81. PubMed ID: 13843702
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experiences with high dosage prednisone therapy and its side-effects in hemoblastosis, especially in plasmocytoma].
    WITTEKIND D; SESSNER HH
    Dtsch Arch Klin Med; 1960; 206():636-62. PubMed ID: 13786084
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of combination 5-fluorouracil and supervoltage irradiation therapy in advanced carcinoma of the urinary bladder--a preliminary report.
    WOODRUFF MW; MURPHY WT; HODSON JM
    Cancer Chemother Rep; 1962 Aug; 21():123-7. PubMed ID: 14008235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.